We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.64B
Cap. Flow %
-83.08%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Real Estate 7.26%
5 Industrials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SZZL
176
DELISTED
Sizzle Acquisition Corp. Common stock
SZZL
$1.76M 0.06%
159,437
-71,665
-31% -$783K
RCFA
177
DELISTED
Perception Capital Corp. IV
RCFA
$1.75M 0.06%
159,438
-71,664
-31% -$787K
NTES icon
178
NetEase
NTES
$83.5B
$1.75M 0.06%
+18,790
New +$2M
DSAQ
179
DELISTED
Direct Selling Acquisition Corp.
DSAQ
$1.75M 0.06%
160,685
-72,226
-31% -$786K
TLGY
180
DELISTED
TLGY Acquisition Corporation Class A Ordinary Share
TLGY
$1.74M 0.05%
156,317
-70,262
-31% -$775K
VEEA
181
Veea Inc
VEEA
$8.82M
$1.74M 0.05%
159,438
-71,664
-31% -$773K
HIW icon
182
Highwoods Properties
HIW
$3.47B
$1.73M 0.05%
75,224
+45,224
+151% +$901K
INSP icon
183
Inspire Medical Systems
INSP
$1.7B
$1.73M 0.05%
8,485
-4,086
-33% -$662K
PDD icon
184
Pinduoduo
PDD
$129B
$1.73M 0.05%
11,795
-19,169
-62% -$2.32M
IVCB
185
DELISTED
Investcorp Europe Acquisition Corp I Class A Ordinary Shares
IVCB
$1.72M 0.05%
156,317
-70,262
-31% -$771K
VICI icon
186
VICI Properties
VICI
$29.2B
$1.72M 0.05%
53,992
-168,995
-76% -$4.96M
FEXD
187
DELISTED
Fintech Ecosystem Development Corp. Class A Common Stock
FEXD
$1.71M 0.05%
159,438
-71,664
-31% -$767K
CSLM
188
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
$1.7M 0.05%
156,317
-70,262
-31% -$758K
TGVC
189
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
$1.7M 0.05%
156,317
-70,262
-31% -$762K
AOGO
190
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
$1.68M 0.05%
156,317
-70,262
-31% -$752K
VERA icon
191
Vera Therapeutics
VERA
$2.3B
$1.65M 0.05%
106,972
-71,019
-40% -$902K
STRO icon
192
Sutro Biopharma
STRO
$400M
$1.62M 0.05%
37,834
+4,834
+15% +$153K
SLN
193
Silence Therapeutics
SLN
$554M
$1.62M 0.05%
93,198
-5,128
-5% -$57.6K
ONON icon
194
On Holding
ONON
$12.4B
$1.62M 0.05%
60,000
-235,000
-80% -$6.4M
MLYS icon
195
Mineralys Therapeutics
MLYS
$2.38B
$1.6M 0.05%
+186,168
New +$1.46M
SRRK icon
196
Scholar Rock
SRRK
$6.41B
$1.6M 0.05%
85,129
-127,452
-60% -$1.58M
FNVT
197
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$1.59M 0.05%
143,494
-64,498
-31% -$708K
ESPR
198
DELISTED
Esperion Therapeutics
ESPR
$1.58M 0.05%
527,123
-104,824
-17% -$136K
FNA
199
DELISTED
Paragon 28, Inc.
FNA
$1.57M 0.05%
126,645
-4,640
-4% -$49.1K
ADT icon
200
ADT
ADT
$5.59B
$1.57M 0.05%
229,607

Similar funds

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.64B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.